longbridge

Kalaris Therapeutics

KLRS
----

All Shareholders

Shareholder Type

  • VC/PE firms54.11%
  • Institutions16.19%
  • Public and others14.27%
  • Individuals & Insiders6.02%
  • Others9.41%

Major Shareholders

Major Shareholders Latest
Shareholder
Samsara BioCapital LLC
54.11%12.88M2.20%-66.91K
RTW Investments, LP
5.46%1.30M0.19%+0
ElevateBio, LLC
3.05%724.99K0.11%+0
Alyeska Investment Group, L.P.
2.41%572.69K0.09%+0
Samir PatelFormer Director & Co-Founder
2.22%528.29K0.08%+0
Napoleone FerraraIndependent Director & Co-Founder
2.12%504.00K0.07%+0
Vanguard Capital Management, LLC
1.95%464.89K0.68%+172.83K
Artal Group S.A.
1.83%435.80K0.06%+0
Ikarian Capital, LLC
1.51%360.00K0.05%+0
UBS Asset Management AG
1.10%262.13K1.07%+255.95K
Morana Jovan-EmbiricosFormer Independent Director
0.91%215.74K0.03%+0
Renaissance Technologies LLC
0.63%149.35K0.34%+83.20K
Marshall Wace LLP
0.58%139.20K0.29%+71.32K
David HallalIndependent Chairman of the Board
0.55%130.55K0.02%+0
Globeways Holdings II Limited
0.53%126.36K0.02%+0
Geode Capital Management, LLC
0.48%114.04K0.10%+26.49K
Woodline Partners LP
0.42%100.00K0.01%+0
ADAR1 Capital Management, LLC
0.42%100.00K0.01%+0
Whi Trust Co Llc
0.41%97.49K0.01%+0
Raymond James Financial, Inc.
0.41%97.16K0.11%-21.72K
© 2026 Longbridge｜Terms of ServicePrivacy Policy